IVD raw materials reach a new milestone! The 37th invention patent has been approved, boosting the efficient development of reagents!
Another triumphant report of medical innovation from Leading Medical.
A carboxylated polystyrene microsphere preservation solution and its applications Patent successfully granted! Leveraging patented technology to address the pain points of microsphere storage, ensuring the stability of core IVD raw materials.
- The problem addressed by this technology
Carboxylated polystyrene microspheres tend to aggregate during long-term storage and are difficult to disperse during EDC/NHS activation and antibody conjugation, thereby compromising the accuracy of experimental results.
- The beneficial effects achieved by this technology
It effectively maintains the long-term stability of the microspheres and their monodispersity during antibody binding, thereby enhancing the accuracy and reliability of experimental results.


The patent portfolio continues to strengthen, underscoring robust innovation capabilities.
As of now, Leading Medical A total of 86 patents have been filed. Among them 52 invention patents , A total of 37 authorized invention patents have been granted. Covering the entire value chain—from microsphere preparation and surface modification to storage stability, antibody development, and kit applications. We continuously leverage proprietary intellectual property to reduce reliance on imports, thereby supporting the domestic substitution of IVD raw materials.
Empowering with chips, safeguarding precise diagnostics.
From microsphere synthesis to long-term stability, and from raw material development to reagent applications, Leading Medical has deeply cultivated the upstream core materials sector for IVD. Backed by a portfolio of patents, it has established a robust technological foundation, delivering more stable, efficient, and reliable raw materials and solutions for biochemical immunoassays, POCT chromatography, quantitative assays, and other applications.
Innovation never stops, and progress never ceases. Leading Medical will continue to drive product upgrades through patent‑driven innovation, providing global IVD companies with a stable supply chain and robust technological support.
Leading Latex Microsphere Product Series



2022-07-26
xy13584019024